Click here to view the Providence Health Plan Medical Policy Updates » September 2024 Providence…
BCBS Kansas City Medical Policy Updates – December 2022
Click here to view the Blue Cross Blue Shield BCBS Kansas City Medical Policy Updates »
December 2022 BCBS Kansas City Medical Policy Updates:
- Adipose-Derived Stem Cells in Autologous Fat Grafting to the Breast
- Adoptive Immunotherapy
- Advanced Therapies for Pharmacologic Treatment of Pulmonary Arterial Hypertension
- Biochemical Markers of Alzheimer Disease and Dementia
- Bone Turnover Markers Testing
- Braftovi (encorafenib)
- BRCA
- Celiac Disease Testing
- Cervical Cancer Screening
- Chimeric Antigen Receptor Therapy for Leukemia and Lymphoma
- Computer-assisted Navigation Orthopedic Procedure
- Cryoablation Radiofrequency Ablation and Laser Ablation for Treatment of Chronic Rhinitis
- Diagnostic Testing of Common Sexually Transmitted Infections
- Diagnostic Testing of Influenza
- Elzonris (tagraxofusp-erzs)
- Epidural Steroid Injections for Neck or Back Pain
- Epithelial Cell Cytology in Breast Cancer Risk Assessment
- Fecal Analysis in the Diagnosis of Intestinal Dysbiosis and Fecal Microbiota Transplant Testing
- Fintepla (fenfluramine)
- General Inflammation Testing
- Genetic Testing and Genetic Expression Profiling in Patients with Cutaneous Melanoma (BRAF)
- Genetic Testing and Genetic Expression Profiling in Patients with Uveal Melanoma
- Genetic Testing for Connective Tissue Disorders
- Genetic Testing for Familial Hypercholesterolemia
- Genetic Testing for Inherited Cardiomyophathies and Channelopathies
- Genetic Testing for Neurodegenerative Disorders
- Hematopoietic Cell Transplantation for Miscellaneous Solid Tumors in Adults
- Hepatitis C Virus (HCV) Direct Acting Antivirals (DAAs)
- Identification of Microorganisms using Nucleic Acid Probes
- Immune Cell Function Assay
- Immunopharmacologic Monitoring of Therapeutic Serum Antibodies
- In Vitro Chemoresistance and Chemosensitivities Assays
- Increlex (mecasermin)
- Injectable Clostridial Collagenase for Fibroproliferative Disorders
- Laboratory Testing for the Diagnosis of Inflammatory Bowel Disease
- Liposuction for Lipedema and Lymphedema
- Lynch Syndrome
- MCG Guidelines – FAQ
- Measurement of Thromboxane Metabolites for ASA Resistance
- Metabolite Markers of Thiopurines Testing
- Microprocessor Controlled Prostheses for the Lower Limb
- Minimal Residual Disease
- Miscellaneous Investigational Procedures
- Molecular Analysis for Gliomas
- Nerve Fiber Density Testing
- Observation Room Services
- Phesgo (pertuzumabtrastuzumaband hyaluronidase-zzxf)
- Reproductive Techniques
- Serum Testing for Hepatic Fibrosis in the Evaluation and Monitoring of Chronic Liver Disease
- Simponi (golimumab)
- Stelara (ustekinumab)
- Steroid-Eluting Sinus Stents
- Taltz (ixekizumab)
- Testing for Diagnosis of Active or Latent Tuberculosis
- Testing for Mosquito- or Tick-Related Infections
- Therapeutic Drug Monitoring for 5-Fluorouracil
- Thyroid Disease Testing
- Total Artificial Hearts and Implantable Ventricular Assist Devices
- Transplant Rejection Testing
- Tremfya (guselkumab)
- Uplizna (inebilizumab-cdon)
- Use of Common Genetic Variants (single nucleotide polymorphisms) to Predict Risk of Non-Familial Breast Cancer
- Verkazia (cyclosporine ophthalmic emulsion 01%)
- Vertebral Fracture Assessment with Densitometry
- Vitamin B12 and Methylmalonic Acid Testing
- Whole Genome and Whole Exome Sequencing
- Xeljanz (tofacitinib)
- Zepzelca (lurbinectedin)
- β-Hemolytic Streptococcus Testing
Click here to view the Blue Cross Blue Shield BCBS Kansas City Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.
Related Posts
